Pruritus as a paraneoplastic syndrome in pediatric hematooncology: a case series
Pruritus is a recognized paraneoplastic manifestation that may accompany malignancy in children, particularly Hodgkin lymphoma (HL). In some patients, pruritus may precede other manifestations of the underlying malignancy and therefore provide an important diagnostic clue. Persistent generalized pruritus without an identifiable dermatologic or systemic cause, particularly when unresponsive to conventional treatment, warrants careful clinical assessment. The following study describes four clinical cases of children aged 12–16 years who presented to the hospital because of unremitting and prolonged pruritus of the skin. In most cases, it was the only symptom of the proliferative disease. It was misdiagnosed for a long time and treated with standard antihistaminic therapy without clinical improvement. Only the performance of imaging studies and the consultation of a pediatric hematooncologist contributed to a correct diagnosis. All patients were treated according to the EuroNetPHL-C2 program with good clinical outcome. Persistent generalized pruritus may represent a paraneoplastic manifestation and, in some patients, may precede the diagnosis of an underlying malignancy. Therefore, unexplained pruritus that persists despite appropriate standard treatment, particularly when accompanied by systemic symptoms, lymphadenopathy, or other abnormal clinical findings, should prompt further diagnostic evaluation.
Authors
- Karol Bigosiński (ORCID: https://orcid.org/0000-0003-3613-3772)
- Małgorzata Mitura-Lesiuk (ORCID: https://orcid.org/0000-0003-1732-0441)
- Maciej Dubaj (ORCID: https://orcid.org/0000-0003-4709-8677)
- Mateusz Raniewicz (ORCID: https://orcid.org/0009-0000-0359-1086)
Institutions
- Medical University of Lublin (PL)
Publication Details
- Journal
- BMC Pediatrics
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1186/s12887-026-08065-x
- Primary Topic
- Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00